🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Retinal vein occlusion (RVO) may lead to series of complications including ...
Status
Unknown
Location
Chuangxin Huang
Start Date
2019-10-01
Trial ID
NCT04062370
Treatments Being Tested
To determine the efficacy of intravitreally (IVT) administered VEGF Trap-Ey...
Status
Completed
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01783886
The purpose of this study is to determine if treatment with infliximab impr...
Status
Terminated
Location
Medical School, University of Athens
Start Date
2007-07
Trial ID
NCT00505947
Treatments Being Tested
To evaluate, specifically within the Canadian medical environment, the effi...
Status
Completed
Location
Calgary Retina Consultants
Start Date
2010-07
Trial ID
NCT01135914
Treatments Being Tested
Study of efficacy and safety of 0.5 mg ranibizumab in Chinese patients with...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-11-05
Trial ID
NCT02259088
Treatments Being Tested
This study is open to adults with diabetic macular ischemia who have receiv...
Status
Completed
Location
California Retina Consultants
Start Date
2021-07-30
Trial ID
NCT04919499
Treatments Being Tested
Background: Age-related macular degeneration (AMD) is a common eye disease ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07744204
Treatments Being Tested
Our hypothesis is that implementing laser photocoagulation (IGTL) as an adj...
Status
Completed
Location
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Start Date
2019-02-12
Trial ID
NCT03751501
Treatments Being Tested
This study was designed to confirm the efficacy and safety of ranibizumab (...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-09
Trial ID
NCT00989989
Treatments Being Tested
This study will assess the efficacy and safety of ranibizumab (intravitreal...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT00901186
Treatments Being Tested